Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8(+) T cells

We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA). BMDCs treated with RG-II had an activated phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sung Nam, Tae Noh, Kyung, Jeong, Young-Il, Duk Jung, In, Kyu Kang, Hyun, Sun Cha, Gil, Jung Lee, Su, Keun Seo, Jong, Hwan Kang, Dae, Hwang, Tae-Ho, Kyung Lee, Eun, Kwon, Byungsuk, Park, Yeong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584663/
https://www.ncbi.nlm.nih.gov/pubmed/23392255
http://dx.doi.org/10.1038/emm.2013.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584663/
https://www.ncbi.nlm.nih.gov/pubmed/23392255
http://dx.doi.org/10.1038/emm.2013.14

Ejemplares similares